A catheter that breaks apart inside the body can support two broad categories of damages: economic damages, meaning documented money losses such as retrieval surgery, hospital stays, lost wages and future care, and non-economic damages, meaning the human harm — pain, disfigurement, loss of enjoyment of life and emotional distress. Which of those a particular patient can actually recover depends less on how badly the catheter failed and more on who is legally responsible and what regulatory pathway the device went through.
A catheter fracture is a recognized device failure, not a freak event. In a series of 1,716 patients with implanted ports, research published in the Journal of International Medical Research found abnormal catheter positioning in 3.0% of cases — 1.8% fractures and 1.2% migrations. That documented baseline matters for a claim, because it establishes that the risk was known and foreseeable to the people who made and placed the device.
Table of Contents
- Economic damages: the costs a fracture creates
- Non-economic damages: the harm no invoice shows
- Two different defendants, two different theories
- How the regulatory paperwork becomes evidence
- Why the device's approval pathway can erase a claim
- Where fracture claims stand in the implanted-port litigation
- Frequently Asked Questions
Economic damages: the costs a fracture creates
The defining economic cost of a fracture is the second procedure. When a fragment breaks loose, it usually has to be fished out of the bloodstream, often from the heart or pulmonary arteries. A 15-year pediatric oncology review reported by researchers at the American University of Beirut found chemoport fracture and migration in seven children, and six of the seven fragments had to be retrieved by loop snaring in the cath lab by pediatric cardiology or interventional radiology.
That means a claim is rarely about a single bill. It typically covers the catheterization lab charges, imaging, anesthesia, the replacement device and its placement, and any inpatient days that follow. Economic damages also extend forward in time. Common categories include:.
- Past medical bills for retrieval, replacement and treatment of complications such as thrombosis or infection
- Future medical care, including monitoring of a fragment that was left in place because retrieval was judged too risky
- Lost wages during recovery, and lost earning capacity if the patient cannot return to the same work
- Out-of-pocket costs: travel to a tertiary center, home health, medical equipment
- Interrupted or delayed treatment costs, which matter most for cancer patients whose chemotherapy access was lost
Non-economic damages: the harm no invoice shows
Non-economic damages compensate what the medical record describes but never prices. For a fracture, the strongest categories are the physical pain of an unplanned invasive retrieval, the fear that comes with being told a piece of plastic has traveled to your heart, and the loss of trust that makes the next needed device feel dangerous. Several fracture-specific harms recur. Scarring from the original site plus the retrieval access site is disfigurement.
A patient who needed a port because their veins were already exhausted may face a permanent loss of reliable venous access. Cancer patients whose treatment was paused often describe a distinct anxiety about lost time, separate from the pain itself. In the most serious cases these claims become wrongful death and survival claims. The FDA received more than 100 reported cases of catheter breakage, including nine patient deaths, associated with catheter entrapment in the ev3 Onyx Liquid Embolic System, and updated physician and patient labeling in April 2012, according to the agency's safety alert from that month. Where a fracture contributes to death, the available damages shift to the survivors: funeral costs, lost financial support, and loss of companionship.
Two different defendants, two different theories
Who you sue shapes what you can claim, and fracture cases usually point in one of two directions. The first is product liability against the manufacturer — the theory that the catheter was defectively designed or made, or that its warnings were inadequate. The second is medical negligence against the clinicians or hospital, and imaging is often where it lives. For percutaneous subclavian central venous catheters, the Cleveland Clinic Journal of Medicine reports fracture with distal embolization at roughly 1.6%, and notes that a catheter showing the radiographic "pinched-off sign" — compression of the line between the clavicle and first rib — carries about a 40% risk of later complete fracture.
A pinched-off catheter visible on a chest film that nobody acted on is a missed warning, and that is a negligence claim independent of whether the device was defective. The two theories are not mutually exclusive, and the distinction has practical consequences. Medical negligence claims are governed by state malpractice rules: shorter deadlines, pre-suit notice or affidavit-of-merit requirements, and in many states statutory caps on non-economic damages. Product claims against a manufacturer usually are not.
How the regulatory paperwork becomes evidence
Device failures generate a federal paper trail, and plaintiffs' lawyers subpoena it. Under 21 CFR Part 803, manufacturers must report to the FDA within 30 calendar days of learning that a device may have caused or contributed to a death or serious injury, or malfunctioned in a way that could; hospitals and other user facilities must report deaths within 10 work days, as set out in the eCFR text of 21 CFR 803.10. Those reports are how a plaintiff shows the manufacturer knew. There is a hard limit on what that data proves, and it is worth understanding before relying on it.
The FDA states that its device-report database "is not intended to be used either to evaluate rates of adverse events… or to compare adverse event occurrence rates across devices," and that a causal link between a product and a reported reaction cannot be established from a report alone. Adverse event counts are notice evidence, not defect evidence — the defect still has to be proven through the device itself, internal company records, and expert analysis. For a patient, the practical takeaway is to preserve the physical evidence. Ask whether the retrieved fragment was kept, request the full imaging series including any pre-fracture films, and get the device's model, lot and serial number from the implant record.
Why the device's approval pathway can erase a claim
The single biggest legal variable is how the device reached the market. In *Riegel v. Medtronic*, decided February 20, 2008 and arising from a balloon catheter that ruptured during angioplasty, the Supreme Court held that 21 U.S.C. § 360k(a) preempts state common-law strict liability, implied warranty and negligent design claims against devices marketed under FDA premarket approval.
The Court's opinion means a patient injured by a PMA-approved device may have no state product claim at all. Most vascular access catheters and implanted ports did not go through premarket approval; they cleared the lower-burden 510(k) pathway, which does not carry the same preemption. So one of the first questions in any fracture case is which pathway the specific device used. The answer can decide whether the manufacturer is a viable defendant or whether the only remaining route is a negligence claim against the clinicians.
Where fracture claims stand in the implanted-port litigation
Fracture is already a named injury in consolidated federal litigation. The Judicial Panel on Multidistrict Litigation consolidated implanted-port claims as MDL 3081 before Judge David G. Campbell in the District of Arizona, and the panel's transfer order lists alleged injuries including infection, fracture of the catheter, migration of the catheter and thrombosis. Plaintiffs allege that an excessive barium sulfate concentration created microscopic cracks and fissures in the catheter material.
Outcomes there are still unsettled. Reporting by the firm Wisner Baum puts the litigation at 3,187 pending actions as of May 1, 2026, and describes the first bellwether, *Cook v. Becton Dickinson*, as beginning April 21, 2026, with Bard prevailing on failure-to-warn and consumer-fraud claims while the jury hung on the central design-defect claim. No fracture-specific bellwether has been tried, which is the concrete point for anyone weighing a claim now: there is no verdict or settlement benchmark for fracture damages in that MDL yet. A case filed today is being valued on its own medical records — the retrieval procedure, the complications, the lost work, the imaging history — not on a published number from a comparable fracture case.
Frequently Asked Questions
Does a fragment left permanently in my body change what I can claim?
It usually expands the future-care component, because a retained fragment judged too risky to remove is typically monitored with ongoing imaging rather than resolved. It also strengthens non-economic claims tied to permanent condition and anxiety.
My catheter fractured years ago. Is it too late?
Deadlines differ sharply by theory and state, and medical negligence claims are frequently shorter than product claims. Because the two theories carry different clocks, the implant date, the fracture date and the date you learned a device problem was suspected all need to be given to a lawyer at the first consultation.
Can I bring a claim if the fracture was caught before it caused symptoms?
Possibly, but damages are narrower. Where a pinched-off catheter is identified and replaced before embolization, the recoverable losses are generally the replacement procedure and related costs rather than the larger injury picture that follows a fragment traveling to the heart.
You Might Also Like
- An Insulin Pump Delivering an Incorrect Dose: Which Economic and Non-Economic Damages Could Be Available?
- A Surgical Robot Malfunction During a Procedure: Which Economic and Non-Economic Damages Could Be Available?
- A Spinal Cord Stimulator Causing Unexpected Nerve Injury: Which Economic and Non-Economic Damages Could Be Available?